The Mission

Savoy Pharmaceuticals™, Inc. was founded to develop innovative therapies in the fields of oncology, virology and immunology. Savoy’s current strategy is to develop therapies through the early phases of clinical trials and then license to or partner with large pharmaceutical companies. Savoy plans to use liver cancer as the catalyst for all other Savoy initiatives. To date, liver cancer is the most prevalent cancer in the world and kills most patients in 1 year.